SecBot SecBot
SECBOTREPLAY Home › Report › TSHA

TSHA · Taysha Gene Therapies granted 714,700 RSUs and an option for 468,600…

Taysha Gene Therapies, Inc. · PRESS-RELEASE filed Jun 5, 2026 at 08:01 ET

At the news

NEUTRALIMPACT 2/10

PRESS-RELEASE filed Jun 5, 2026 at 08:01 ET

Taysha Gene Therapies granted 714,700 RSUs and an option for 468,600 shares to four new employees under its 2023 Inducement Plan, with a $5.97 exercise price. This is a routine equity inducement grant for new hires, not a material operational or financial event.

  • 714,700 RSUs and an option for 468,600 shares granted to four new employees on June 1, 2026
  • Stock option exercise price set at $5.97, equal to the closing price on grant date
  • RSUs vest in four equal annual installments; option vests 25% on first anniversary, then monthly over 36 months
  • Grant made under the 2023 Inducement Plan per Nasdaq Listing Rule 5635(c)(4)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access